pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·7h ago·1 min read
save

IRS launches probe into UnitedHealth over alleged tax avoidance from 2017-2020

Aug 17, 2026·read at STAT ↗RegulatoryNegative

UnitedHealth Group is under investigation by the Internal Revenue Service, which says the insurer underpaid taxes by moving money to a foreign subsidiary during 2017-2020.

The IRS is seeking to increase UnitedHealth's taxable income for that period and may also adjust taxes for years after 2020. UnitedHealth disclosed the IRS notices in a recent regulatory filing, noting they were received in March.

Audits of this kind are uncommon and focus on profit-shifting within large corporations. Given UnitedHealth's status as one of the world’s biggest revenue generators, the probe could involve a significant financial liability.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: UnitedHealth faces IRS probe over potential tax avoidance”

read at STAT ↗
514 words · retrieved 7h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
ELI LILLY COLILLYUltragenyx Pharmaceutical Inc.
topics
Rare Disease

related stories

  • Jul 10STAT+: Pharmalittle: We’re reading about bigger drug discounts in Germany, drugmakers embracing secrecy, and moreSTAT
  • Jul 9STAT+: Pharmalittle: We’re reading about FDA commissioner contenders, a heart drug failure, and moreSTAT
  • Jul 8STAT+: Pharmalittle: We’re reading about a Vera kidney drug approval, a U.K. Enhertu pricing deal, and moreSTAT
  • Jul 7Oberland pours up to $400M into MeiraGTx eye gene therapiesBioPharma Dive
  • Jul 7STAT+: Pharmalittle: We’re reading about a $10 billion Vertex deal, the pace of FDA drug approvals, and moreSTAT